Low-dose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects

Nutrition Research

Volumn 32, Issue 1, 2012, Pages 15-23

  Gammelmark, Anders ^a   Madsen, Trine ^a   Varming, Kim ^a   Lundbye Christensen, Søren ^a   Schmidt, Erik B ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adiponectin; Inflammation; N 3 PUFA; Overweight; Randomized controlled trial

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; APOLIPOPROTEIN B; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FISH OIL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PLACEBO; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FATTY ACID ANALYSIS; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GRANULOCYTE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOSE TISSUE; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FISH OILS; HUMANS; INFLAMMATION; INTERLEUKIN-6; LINEAR MODELS; MALE; MIDDLE AGED; OVERWEIGHT; PLANT OILS; QUESTIONNAIRES;

EID: 84855962115     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.12.007     Document Type: Article

References (47)

1. Balkau B., Deanfield J.E., Despres J.P., Bassand J.P., Fox K.A., Smith S.C., et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007, 116(17):1942-1951.
2. Hajer G.R., van Haeften T.W., Visseren F.L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008, 29(24):2959-2971.
3. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92(3):347-355.
4. Bjerregaard L.J., Joensen A.M., Dethlefsen C., Jensen M.K., Johnsen S.P., Tjonneland A., et al. Fish intake and acute coronary syndrome. Eur Heart J 2010, 31(1):29-34.
5. He K., Song Y., Daviglus M.L., Liu K., Van H.L., Dyer A.R., et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004, 109(22):2705-2711.
6. Schmidt E.B., Arnesen H., Christensen J.H., Rasmussen L.H., Kristensen S.D., de C.R. Marine n-3 polyunsaturated fatty acids and coronary heart disease: part II. clinical trials and recommendations. Thromb Res 2005, 115(4):257-262.
7. GISSI-Prevenzione investigators Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999, 354(9177):447-455.
8. Burr M.L., Fehily A.M., Gilbert J.F., Rogers S., Holliday R.M., Sweetnam P.M., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 2(8666):757-761.
9. Schmidt E.B., Arnesen H., de C.R., Rasmussen L.H., Kristensen S.D. Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety. Thromb Res 2005, 115(3):163-170.
10. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105(9):1135-1143.
11. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340(2):115-126.
12. Calder P.C. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 2004, 107(1):1-11.
13. Browning L.M., Krebs J.D., Moore C.S., Mishra G.D., O'Connell M.A., Jebb S.A. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 2007, 9(1):70-80.
14. WHO Expert Committee Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995, 854:1-452.
15. Schmidt E.B., Varming K., Moller J.M., Bulow P., Madsen P., Dyerberg J. No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans. Scand J Clin Lab Invest 1996, 56(1):87-92.
16. van Kuijk F.J., Thomas D.W., Stephens R.J., Dratz E.A. Gas chromatography-mass spectrometry method for determination of phospholipid peroxides; I. Transesterification to form methyl esters. J Free Radic Biol Med 1985, 1(3):215-225.
17. National Food Institute, Technical University of Denmark. National Food Institute 2011. http://foodcomp.dk/v7/fvdb_search.asp.
18. Flachs P., Mohamed-Ali V., Horakova O., Rossmeisl M., Hosseinzadeh-Attar M.J., Hensler M., et al. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 2006, 49(2):394-397.
19. Rossi A.S., Lombardo Y.B., Lacorte J.M., Chicco A.G., Rouault C., Slama G., et al. Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am J Physiol Regul Integr Comp Physiol 2005, 289(2):R486-R494.
20. Neschen S., Morino K., Rossbacher J.C., Pongratz R.L., Cline G.W., Sono S., et al. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. Diabetes 2006, 55(4):924-928.
21. Itoh M., Suganami T., Satoh N., Tanimoto-Koyama K., Yuan X., Tanaka M., et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 2007, 27(9):1918-1925.
22. Guebre-Egziabher F., Rabasa-Lhoret R., Bonnet F., Bastard J.P., Desage M., Skilton M.R., et al. Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects. Eur J Clin Nutr 2008, 62(11):1287-1293.
23. Sneddon A.A., Tsofliou F., Fyfe C.L., Matheson I., Jackson D.M., Horgan G., et al. Effect of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin. Obesity (Silver Spring) 2008, 16(5):1019-1024.
24. Rasmussen J.G., Christensen J.H., Schmidt E.B. Adiponectin and marine n-3 fatty acids in patients referred for coronary angiography. Int J Cardiol 2009, 135(2):248-250.
25. Esposito K., Pontillo A., Di P.C., Giugliano G., Masella M., Marfella R., et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003, 289(14):1799-1804.
26. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001, 86(8):3815-3819.
27. Kriketos A.D., Robertson R.M., Sharp T.A., Drougas H., Reed G.W., Storlien L.H., et al. Role of weight loss and polyunsaturated fatty acids in improving metabolic fitness in moderately obese, moderately hypertensive subjects. J Hypertens 2001, 19(10):1745-1754.
28. Mori T.A., Bao D.Q., Burke V., Puddey I.B., Watts G.F., Beilin L.J. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 1999, 70(5):817-825.
29. Kratz M., Swarbrick M.M., Callahan H.S., Matthys C.C., Havel P.J., Weigle D.S. Effect of dietary n-3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. Am J Clin Nutr 2008, 87(2):347-353.
30. He K., Liu K., Daviglus M.L., Jenny N.S., Mayer-Davis E., Jiang R., et al. Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 2009, 103(9):1238-1243.
31. Micallef M.A., Garg M.L. Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 2009, 204(2):476-482.
32. Madsen T., Christensen J.H., Blom M., Schmidt E.B. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr 2003, 89(4):517-522.
33. de R.B., Mavrommatis Y., Brouwer I.A. Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol 2009, 158(2):413-428.
34. Calder P.C. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002, 61(3):345-358.
35. Schubert R., Kitz R., Beermann C., Rose M.A., Baer P.C., Zielen S., et al. Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of healthy adults. Nutrition 2007, 23(10):724-730.
36. Pot G.K., Brouwer I.A., Enneman A., Rijkers G.T., Kampman E., Geelen A. No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals. Eur J Clin Nutr 2009, 63(11):1353-1359.
37. Murphy K.J., Galvin K., Kiely M., Morrissey P.A., Mann N.J., Sinclair A.J. Low dose supplementation with two different marine oils does not reduce pro-inflammatory eicosanoids and cytokines in vivo. Asia Pac J Clin Nutr 2006, 15(3):418-424.
38. Calder P.C. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 2006, 75(3):197-202.
39. Lee T.H., Hoover R.L., Williams J.D., Sperling R.I., Ravalese J., Spur B.W., et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985, 312(19):1217-1224.
40. Healy D.A., Wallace F.A., Miles E.A., Calder P.C., Newsholm P. Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 2000, 35(7):763-768.
41. Bagga D., Wang L., Farias-Eisner R., Glaspy J.A., Reddy S.T. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003, 100(4):1751-1756.
42. Novak T.E., Babcock T.A., Jho D.H., Helton W.S., Espat N.J. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol 2003, 284(1):L84-L89.
43. Chambrier C., Bastard J.P., Rieusset J., Chevillotte E., Bonnefont-Rousselot D., Therond P., et al. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes Res 2002, 10(6):518-525.
44. Van de W.F., Ardissino D., Betriu A., Cokkinos D.V., Falk E., Fox K.A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003, 24(1):28-66.
45. Kris-Etherton P.M., Harris W.S., Appel L.J. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 2003, 23(2):151-152.
46. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107(3):499-511.
47. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257(1):79-83.